Physician profile
Jay Patrick Lopez
NPI 1164788444
$4,410.30
in general payments reported to CMS, 2019-2025
10 companies · $4,101 in 2025
The $4,101 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.06 · 2020: $17.91 · 2021: $174 · 2022: $20.10 · 2025: $4,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,765 · Food and Beverage: $323 · Travel and Lodging: $13.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,765.00 |
| Food and Beverage | $323.00 |
| Travel and Lodging | $13.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $2,400.00 | 2025 | |
| Genmab U.S., INC. | $1,506.08 | 2025 | Epkinly |
| Alexion Pharmaceuticals, INC. | $150.00 | 2021 | |
| Boston Scientific Corporation | $141.57 | 2025 | Exalt Model D |
| Theratechnologies INC. | $97.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.01 | 2020-2022 | |
| Daiichi Sankyo INC. | $37.66 | 2025 | Enhertu |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Adc Therapeutics America, INC. | $15.99 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.